Clinical trial
Use of Ultiva ® Associated With Xylocaine ® in the Procedures of Feticide: A Phase III Randomized Trial
NCT02597699 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Ultiva ® Associated With Xylocaine ® in the Procedures of Feticide: A Phase III Randomized Trial
- Lead sponsor
- University Hospital, Montpellier
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 18, 2015
- Completion date
- May 6, 2019
- Enrollment
- 66 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
feticide, termination of pregnancy